Diagnostic News and Research

RSS

Duke engineers awarded NSF grant to adapt fast, low-cost diagnostic tool for COVID-19

Biomedical engineers at Duke University are adapting a rapid testing platform originally designed to detect Ebola to see whether it could be of use in detecting antigens to SARS-Cov-2, the virus that causes COVID-19.

27 Apr 2020

Consumer beware: Coronavirus antibody tests are still a work in progress

After hearing for months about serious access issues involving tests that diagnose COVID-19 based on swabs from the nose or throat, Americans are being inundated with reports about promising new tests that look for signs of infection in the blood.

27 Apr 2020

Decreasing early neuroinflammation could slow Alzheimer's progression

In a new animal study examining Alzheimer's disease, researchers found that disease progression could be slowed by decreasing neuroinflammation in the brain before memory problems and cognitive impairment were apparent.

27 Apr 2020

See Beyond Border – You're invited to join Mindray's ME series online global launch event

Nowadays, COVID-19 has spread around the world, threatening billions of people as healthcare services struggle to cope. World Health Organization has now officially characterized it as a pandemic, calling for immediate and wise reactions.

From Mindray 27 Apr 2020

Free open source hardware could be used to fight against coronavirus

Free open source hardware and 3D printing could help to alleviate the burden of Covid-19 on global health systems, according to scientists at the University of Sussex.

27 Apr 2020

Researchers re-purpose cancer-fighting artificial antibodies for COVID-19

Researcher Paula Bates, John Trent, and Don Miller developed a therapeutic drug that could potentially block the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the COVID-19 pandemic. Their research was initially aimed at helping patients suffering from multiple types of cancer.

27 Apr 2020

Rice University looks to ‘trap and zap’ SARS-CoV-2 in wastewater

A team of researchers from Rice University has won a National Science Foundation (NSF) RAPID grant to adapt their wastewater nanotechnology project to help trap and inactivate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), (which causes COVID-19 disease), in wastewater. This could help public health officials deal with the threat of disease transmission through wastewater.

27 Apr 2020

A new test for rapid large-scale testing of COVID-19

OU Medicine, the OU Health Sciences Center and the Oklahoma Medical Research Foundation collaborated to create a new test for COVID-19 using technology and reagents from Fluidigm Corporation, an innovative biotechnology tools provider

25 Apr 2020

Study adds a new dimension to heart disease

Using the Canadian Light Source (CLS) at the University of Saskatchewan, Marta Cerruti, an Associate Professor in McGill's Department of Materials Engineering, and her team analyzed damaged heart valves from patients who had undergone transplants.

25 Apr 2020

New computer model predicts suicide risk

Suicide is now the second most common cause of death among American youth. Fatal suicides rose 30 percent between 2000 and 2016, and 2016 alone saw 1.3 million nonfatal suicide attempts.

25 Apr 2020

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic

Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.

From Siemens Healthineers Point of Care Diagnostics 24 Apr 2020

Mologic launches laboratory-based diagnostic test for COVID-19

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it will begin manufacturing its laboratory diagnostic test for COVID-19.

24 Apr 2020

Australian researchers develop world’s first ultrasound biosensor

Australian researchers have made a world-first breakthrough that has the potential to monitor the changes in pH levels and other responses to therapy in stroke and cancer patients.

24 Apr 2020

Top biochip firms speed up development of fast, reliable COVID-19 test

Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.

24 Apr 2020

Research looks at best ways to tackle coronavirus crisis

A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.

24 Apr 2020

New report highlights blood clot dangers in patients with COVID-19

A special report published today in the journal Radiology outlines prevention, diagnosis and treatment of complications stemming from blood clots in patients with COVID-19. The journal also published two research letters and a case study on this topic.

23 Apr 2020

Poor quality testing could increase number of COVID-19 infections

A new study published in the preprint open-access journal medRxiv in April 2020 assesses the value of untargeted testing for infection or immunity in COVID-19 vs. high-quality targeted testing in keeping down the number of infections while slowly relaxing lockdown measures.

23 Apr 2020

New nanobiosensor can help diagnose early-stage multiple sclerosis

Researchers at the Federal University of São Carlos in Sorocaba have developed a technique to diagnose early-stage multiple sclerosis, a disease of the central nervous system, and distinguish it from neuromyelitis optica, a rare yet severe autoimmune inflammatory process also affecting the central nervous system.

23 Apr 2020

Abbott’s fast COVID test poses safety issues, lab workers say

Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded - particularly, the risk of infection to those handling it.

23 Apr 2020

Novel method may enable decentralized facilities to deliver faster COVID-19 test services

The COVID-19 pandemic has resulted in over 2.5 million confirmed cases worldwide and nearly over 170,000 deaths as of April 21 according to the World Health Organization.

23 Apr 2020